Home Data Calendar Blog

ME

Tables

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Common Stock Value 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.00 0.00 NA NA

Weighted Average Number Of Diluted Shares Outstanding 474.86 462.25 NA 453.41 449.90 446.51 NA 426.59 406.89 168.19 NA NA NA NA

Weighted Average Number Of Shares Outstanding Basic 474.86 462.25 NA 453.41 449.90 446.51 NA 426.59 406.89 168.19 NA NA NA NA

Earnings Per Share Basic And Diluted NA NA NA NA NA NA -0.16 -0.21 -0.04 -0.25 -0.61 -0.46 0.00 -0.38

Income Loss From Continuing Operations Per Basic Share -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 NA NA NA NA

Income Loss From Continuing Operations Per Diluted Share -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 NA NA NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Common Stock Value	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.00	0.00	NA	NA
Weighted Average Number Of Diluted Shares Outstanding	474.86	462.25	NA	453.41	449.90	446.51	NA	426.59	406.89	168.19	NA	NA	NA	NA
Weighted Average Number Of Shares Outstanding Basic	474.86	462.25	NA	453.41	449.90	446.51	NA	426.59	406.89	168.19	NA	NA	NA	NA
Earnings Per Share Basic And Diluted	NA	NA	NA	NA	NA	NA	-0.16	-0.21	-0.04	-0.25	-0.61	-0.46	0.00	-0.38
Income Loss From Continuing Operations Per Basic Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	NA	NA	NA	NA
Income Loss From Continuing Operations Per Diluted Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	NA	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Revenue From Contract With Customer Including Assessed Tax 50.00 60.86 92.38 66.94 75.66 64.51 100.56 56.89 55.20 59.24 88.58 55.48 51.80 48.06

Revenues 50.00 60.86 92.38 66.94 75.66 64.51 100.56 56.89 55.20 59.24 88.58 55.48 51.80 48.06

Cost Of Revenue 28.27 30.18 52.40 36.19 37.39 39.02 53.50 29.63 27.28 28.54 44.05 30.09 27.21 25.56

Gross Profit 21.73 30.68 39.98 30.75 38.27 25.49 47.06 27.26 27.93 30.70 44.53 25.39 24.59 22.49

Operating Expenses 100.86 139.94 109.26 127.85 106.31 115.09 116.51 123.96 74.38 72.25 111.61 70.53 60.85 59.22

Research And Development Expense 54.59 62.33 60.72 57.27 52.60 52.01 50.32 50.30 44.52 44.23 45.60 41.68 38.20 34.37

General And Administrative Expense 25.29 50.74 26.76 30.70 28.88 29.64 36.84 31.69 16.26 12.60 54.05 16.59 14.31 14.19

Selling And Marketing Expense 18.33 22.66 21.78 39.88 24.84 33.43 29.35 41.98 13.59 15.42 11.96 12.26 8.33 10.65

Litigation Settlement Expense 0.10 NA NA NA NA NA NA NA NA NA NA NA NA NA

Operating Income Loss -79.13 -109.26 -69.27 -97.10 -68.04 -89.60 -69.45 -96.70 -46.45 -41.55 -2.67 -45.14 -36.25 -36.72

Interest Income Expense Net 3.75 4.31 4.37 3.67 1.39 0.24 0.06 0.08 0.09 0.04 0.06 0.05 0.07 0.07

Allocated Share Based Compensation Expense 23.74 51.10 NA NA 28.97 30.46 20.46 17.41 10.43 9.64 51.20 14.99 10.80 9.70

Income Tax Expense Benefit 0.04 NA -0.63 -0.61 1.27 -0.25 0.03 -3.51 NA NA NA NA NA NA

Profit Loss -75.27 -104.62 -64.10 -91.96 -66.06 -89.53 -69.54 -89.40 -16.52 -42.03 -67.01 -44.65 -36.19 -35.77

Other Comprehensive Income Loss Net Of Tax 0.95 -0.33 -0.31 -1.94 0.83 0.62 0.21 -0.04 NA NA NA NA NA NA

Net Income Loss -75.27 -104.62 -64.10 -91.96 -66.06 -89.53 -69.54 -89.40 -16.52 -42.03 23.30 -44.65 -0.00 -0.00

Comprehensive Income Net Of Tax -74.32 -104.96 -64.41 -93.90 -65.24 -88.91 -69.33 -89.43 -16.52 -42.03 -67.01 -44.65 NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Revenue From Contract With Customer Including Assessed Tax	50.00	60.86	92.38	66.94	75.66	64.51	100.56	56.89	55.20	59.24	88.58	55.48	51.80	48.06
Revenues	50.00	60.86	92.38	66.94	75.66	64.51	100.56	56.89	55.20	59.24	88.58	55.48	51.80	48.06
Cost Of Revenue	28.27	30.18	52.40	36.19	37.39	39.02	53.50	29.63	27.28	28.54	44.05	30.09	27.21	25.56
Gross Profit	21.73	30.68	39.98	30.75	38.27	25.49	47.06	27.26	27.93	30.70	44.53	25.39	24.59	22.49
Operating Expenses	100.86	139.94	109.26	127.85	106.31	115.09	116.51	123.96	74.38	72.25	111.61	70.53	60.85	59.22
Research And Development Expense	54.59	62.33	60.72	57.27	52.60	52.01	50.32	50.30	44.52	44.23	45.60	41.68	38.20	34.37
General And Administrative Expense	25.29	50.74	26.76	30.70	28.88	29.64	36.84	31.69	16.26	12.60	54.05	16.59	14.31	14.19
Selling And Marketing Expense	18.33	22.66	21.78	39.88	24.84	33.43	29.35	41.98	13.59	15.42	11.96	12.26	8.33	10.65
Litigation Settlement Expense	0.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating Income Loss	-79.13	-109.26	-69.27	-97.10	-68.04	-89.60	-69.45	-96.70	-46.45	-41.55	-2.67	-45.14	-36.25	-36.72
Interest Income Expense Net	3.75	4.31	4.37	3.67	1.39	0.24	0.06	0.08	0.09	0.04	0.06	0.05	0.07	0.07
Allocated Share Based Compensation Expense	23.74	51.10	NA	NA	28.97	30.46	20.46	17.41	10.43	9.64	51.20	14.99	10.80	9.70
Income Tax Expense Benefit	0.04	NA	-0.63	-0.61	1.27	-0.25	0.03	-3.51	NA	NA	NA	NA	NA	NA
Profit Loss	-75.27	-104.62	-64.10	-91.96	-66.06	-89.53	-69.54	-89.40	-16.52	-42.03	-67.01	-44.65	-36.19	-35.77
Other Comprehensive Income Loss Net Of Tax	0.95	-0.33	-0.31	-1.94	0.83	0.62	0.21	-0.04	NA	NA	NA	NA	NA	NA
Net Income Loss	-75.27	-104.62	-64.10	-91.96	-66.06	-89.53	-69.54	-89.40	-16.52	-42.03	23.30	-44.65	-0.00	-0.00
Comprehensive Income Net Of Tax	-74.32	-104.96	-64.41	-93.90	-65.24	-88.91	-69.33	-89.43	-16.52	-42.03	-67.01	-44.65	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Assets 801.23 871.20 942.60 1024.65 1040.73 1062.23 1152.07 1226.32 903.04 947.02 509.19 509.88 NA NA

Liabilities 175.98 195.71 228.66 273.66 221.41 208.03 236.41 265.14 243.53 284.48 64.13 88.12 NA NA

Liabilities And Stockholders Equity 801.23 871.20 942.60 1024.65 1040.73 1062.23 1152.07 1226.32 903.04 947.02 509.19 509.88 NA NA

Stockholders Equity 625.25 675.49 713.94 750.99 819.32 854.20 915.66 961.17 659.51 662.54 5.00 5.00 0.01 0.01

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Assets	801.23	871.20	942.60	1024.65	1040.73	1062.23	1152.07	1226.32	903.04	947.02	509.19	509.88	NA	NA
Liabilities	175.98	195.71	228.66	273.66	221.41	208.03	236.41	265.14	243.53	284.48	64.13	88.12	NA	NA
Liabilities And Stockholders Equity	801.23	871.20	942.60	1024.65	1040.73	1062.23	1152.07	1226.32	903.04	947.02	509.19	509.88	NA	NA
Stockholders Equity	625.25	675.49	713.94	750.99	819.32	854.20	915.66	961.17	659.51	662.54	5.00	5.00	0.01	0.01

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Assets Current 298.00 360.28 424.99 508.67 506.20 519.81 601.79 669.86 769.38 814.66 0.46 1.24 NA NA

Cash 256.39 314.35 386.85 432.80 410.89 479.40 553.18 586.20 701.05 769.94 282.49 288.69 177.11 172.12

Cash And Cash Equivalents At Carrying Value 256.39 314.35 386.85 432.80 410.89 479.40 553.18 586.20 701.05 769.94 0.08 0.79 0.02 NA

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 264.76 322.72 395.22 441.17 419.46 487.97 561.75 594.78 709.42 778.31 290.86 297.06 185.48 180.49

Accounts Receivable Net Current 1.50 4.12 1.90 26.81 52.88 2.92 3.38 23.56 26.71 9.40 2.48 NA NA NA

Inventory Net 14.98 11.81 10.25 11.96 13.81 11.46 10.79 17.13 17.73 15.27 6.24 NA NA NA

Prepaid Expense And Other Assets Current 17.95 21.29 19.22 21.37 20.24 17.88 25.14 25.25 16.96 12.53 15.48 NA NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Assets Current	298.00	360.28	424.99	508.67	506.20	519.81	601.79	669.86	769.38	814.66	0.46	1.24	NA	NA
Cash	256.39	314.35	386.85	432.80	410.89	479.40	553.18	586.20	701.05	769.94	282.49	288.69	177.11	172.12
Cash And Cash Equivalents At Carrying Value	256.39	314.35	386.85	432.80	410.89	479.40	553.18	586.20	701.05	769.94	0.08	0.79	0.02	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents	264.76	322.72	395.22	441.17	419.46	487.97	561.75	594.78	709.42	778.31	290.86	297.06	185.48	180.49
Accounts Receivable Net Current	1.50	4.12	1.90	26.81	52.88	2.92	3.38	23.56	26.71	9.40	2.48	NA	NA	NA
Inventory Net	14.98	11.81	10.25	11.96	13.81	11.46	10.79	17.13	17.73	15.27	6.24	NA	NA	NA
Prepaid Expense And Other Assets Current	17.95	21.29	19.22	21.37	20.24	17.88	25.14	25.25	16.96	12.53	15.48	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Property Plant And Equipment Gross 113.57 113.47 113.92 112.97 113.89 113.14 112.47 111.07 110.16 112.12 111.21 NA NA NA

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 80.76 77.76 75.32 72.18 69.84 66.23 62.62 58.82 56.41 54.42 50.33 NA NA NA

Amortization Of Intangible Assets 3.80 3.80 3.90 4.50 4.50 4.50 4.60 3.00 NA NA NA NA NA NA

Property Plant And Equipment Net 32.80 35.70 38.61 40.79 44.06 46.91 49.85 52.25 53.75 57.70 60.88 NA NA NA

Goodwill 351.74 351.74 351.74 351.74 351.74 351.74 351.74 351.60 NA NA NA NA NA NA

Indefinite Lived Intangible Assets Excluding Goodwill 37.84 41.68 45.52 49.36 64.93 69.39 73.91 78.46 NA NA NA NA NA NA

Finite Lived Intangible Assets Net 37.84 41.68 45.52 49.36 64.93 69.39 73.91 78.46 NA NA NA NA NA NA

Other Assets Noncurrent 2.36 2.61 3.02 3.30 3.43 3.36 2.59 1.38 6.81 0.55 0.65 NA NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Property Plant And Equipment Gross	113.57	113.47	113.92	112.97	113.89	113.14	112.47	111.07	110.16	112.12	111.21	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment	80.76	77.76	75.32	72.18	69.84	66.23	62.62	58.82	56.41	54.42	50.33	NA	NA	NA
Amortization Of Intangible Assets	3.80	3.80	3.90	4.50	4.50	4.50	4.60	3.00	NA	NA	NA	NA	NA	NA
Property Plant And Equipment Net	32.80	35.70	38.61	40.79	44.06	46.91	49.85	52.25	53.75	57.70	60.88	NA	NA	NA
Goodwill	351.74	351.74	351.74	351.74	351.74	351.74	351.74	351.60	NA	NA	NA	NA	NA	NA
Indefinite Lived Intangible Assets Excluding Goodwill	37.84	41.68	45.52	49.36	64.93	69.39	73.91	78.46	NA	NA	NA	NA	NA	NA
Finite Lived Intangible Assets Net	37.84	41.68	45.52	49.36	64.93	69.39	73.91	78.46	NA	NA	NA	NA	NA	NA
Other Assets Noncurrent	2.36	2.61	3.02	3.30	3.43	3.36	2.59	1.38	6.81	0.55	0.65	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Liabilities Current 101.60 118.91 149.42 200.11 144.91 127.81 153.24 179.55 113.63 122.67 121.62 NA NA NA

Accounts Payable Current 8.55 12.75 12.92 13.98 10.55 18.05 37.93 14.42 10.28 17.68 12.27 NA NA NA

Accrued Liabilities Current 44.69 50.22 66.43 69.04 44.42 52.04 44.59 46.30 29.54 33.03 1.63 0.03 NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Liabilities Current	101.60	118.91	149.42	200.11	144.91	127.81	153.24	179.55	113.63	122.67	121.62	NA	NA	NA
Accounts Payable Current	8.55	12.75	12.92	13.98	10.55	18.05	37.93	14.42	10.28	17.68	12.27	NA	NA	NA
Accrued Liabilities Current	44.69	50.22	66.43	69.04	44.42	52.04	44.59	46.30	29.54	33.03	1.63	0.03	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Other Liabilities Noncurrent 1.42 1.39 1.48 2.11 2.64 3.98 4.65 4.76 1.21 1.19 1.17 NA NA NA

Operating Lease Liability Noncurrent 72.96 75.41 77.76 71.44 73.87 76.24 78.52 80.83 82.57 84.67 87.58 NA NA NA

		2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Other Liabilities Noncurrent		1.42	1.39	1.48	2.11	2.64	3.98	4.65	4.76	1.21	1.19	1.17	NA	NA	NA
Operating Lease Liability Noncurrent		72.96	75.41	77.76	71.44	73.87	76.24	78.52	80.83	82.57	84.67	87.58	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Stockholders Equity 625.25 675.49 713.94 750.99 819.32 854.20 915.66 961.17 659.51 662.54 5.00 5.00 0.01 0.01

Common Stock Value 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.00 0.00 NA NA

Additional Paid In Capital Common Stock 2311.48 2287.41 2220.90 2193.54 2167.97 2137.61 2110.16 2086.35 1695.26 1681.77 381.62 NA NA NA

Retained Earnings Accumulated Deficit -1686.28 -1611.01 -1506.38 -1442.29 -1350.33 -1284.26 -1194.73 -1125.18 -1035.79 -1019.26 -25.31 -48.60 NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax NA -0.95 -0.62 -0.31 1.63 0.80 0.18 -0.04 NA NA NA NA NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Stockholders Equity	625.25	675.49	713.94	750.99	819.32	854.20	915.66	961.17	659.51	662.54	5.00	5.00	0.01	0.01
Common Stock Value	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.00	0.00	NA	NA
Additional Paid In Capital Common Stock	2311.48	2287.41	2220.90	2193.54	2167.97	2137.61	2110.16	2086.35	1695.26	1681.77	381.62	NA	NA	NA
Retained Earnings Accumulated Deficit	-1686.28	-1611.01	-1506.38	-1442.29	-1350.33	-1284.26	-1194.73	-1125.18	-1035.79	-1019.26	-25.31	-48.60	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax	NA	-0.95	-0.62	-0.31	1.63	0.80	0.18	-0.04	NA	NA	NA	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Net Cash Provided By Used In Operating Activities -57.12 -69.36 -44.96 25.55 -72.93 -73.04 -35.20 -24.60 -62.49 -44.53 -40.27 28.43 -29.51 -32.91

Net Cash Provided By Used In Investing Activities -2.77 -2.69 -3.29 -3.07 -2.05 -2.90 -3.20 -95.82 -7.73 -1.39 -0.79 -0.74 -1.05 -3.95

Net Cash Provided By Used In Financing Activities 1.59 -0.11 2.61 -0.01 5.65 1.53 5.52 5.78 1.33 533.37 0.30 83.89 35.56 1.03

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Operating Activities	-57.12	-69.36	-44.96	25.55	-72.93	-73.04	-35.20	-24.60	-62.49	-44.53	-40.27	28.43	-29.51	-32.91
Net Cash Provided By Used In Investing Activities	-2.77	-2.69	-3.29	-3.07	-2.05	-2.90	-3.20	-95.82	-7.73	-1.39	-0.79	-0.74	-1.05	-3.95
Net Cash Provided By Used In Financing Activities	1.59	-0.11	2.61	-0.01	5.65	1.53	5.52	5.78	1.33	533.37	0.30	83.89	35.56	1.03

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Net Cash Provided By Used In Operating Activities -57.12 -69.36 -44.96 25.55 -72.93 -73.04 -35.20 -24.60 -62.49 -44.53 -40.27 28.43 -29.51 -32.91

Net Income Loss -75.27 -104.62 -64.10 -91.96 -66.06 -89.53 -69.54 -89.40 -16.52 -42.03 23.30 -44.65 -0.00 -0.00

Profit Loss -75.27 -104.62 -64.10 -91.96 -66.06 -89.53 -69.54 -89.40 -16.52 -42.03 -67.01 -44.65 -36.19 -35.77

Increase Decrease In Accounts Receivable -2.62 2.23 -24.91 -26.07 49.96 -0.46 -20.18 -3.15 31.15 -6.92 -2.65 -21.50 18.36 1.88

Increase Decrease In Inventories 3.17 1.57 -1.71 -1.84 2.34 0.67 -6.34 -0.89 20.53 -9.03 -10.01 3.78 -4.50 2.85

Increase Decrease In Accounts Payable -3.95 -0.00 -1.27 3.66 -7.81 -19.15 23.66 0.19 -6.72 5.72 0.35 3.99 2.52 -6.72

Deferred Income Tax Expense Benefit NA NA -4.90 0.60 1.30 0.30 0.00 3.50 NA NA 0.00 NA NA NA

Share Based Compensation 23.74 51.10 22.25 34.34 28.97 30.46 20.46 17.41 10.43 9.64 51.20 14.99 10.87 11.36

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Operating Activities	-57.12	-69.36	-44.96	25.55	-72.93	-73.04	-35.20	-24.60	-62.49	-44.53	-40.27	28.43	-29.51	-32.91
Net Income Loss	-75.27	-104.62	-64.10	-91.96	-66.06	-89.53	-69.54	-89.40	-16.52	-42.03	23.30	-44.65	-0.00	-0.00
Profit Loss	-75.27	-104.62	-64.10	-91.96	-66.06	-89.53	-69.54	-89.40	-16.52	-42.03	-67.01	-44.65	-36.19	-35.77
Increase Decrease In Accounts Receivable	-2.62	2.23	-24.91	-26.07	49.96	-0.46	-20.18	-3.15	31.15	-6.92	-2.65	-21.50	18.36	1.88
Increase Decrease In Inventories	3.17	1.57	-1.71	-1.84	2.34	0.67	-6.34	-0.89	20.53	-9.03	-10.01	3.78	-4.50	2.85
Increase Decrease In Accounts Payable	-3.95	-0.00	-1.27	3.66	-7.81	-19.15	23.66	0.19	-6.72	5.72	0.35	3.99	2.52	-6.72
Deferred Income Tax Expense Benefit	NA	NA	-4.90	0.60	1.30	0.30	0.00	3.50	NA	NA	0.00	NA	NA	NA
Share Based Compensation	23.74	51.10	22.25	34.34	28.97	30.46	20.46	17.41	10.43	9.64	51.20	14.99	10.87	11.36

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Net Cash Provided By Used In Investing Activities -2.77 -2.69 -3.29 -3.07 -2.05 -2.90 -3.20 -95.82 -7.73 -1.39 -0.79 -0.74 -1.05 -3.95

Payments To Acquire Property Plant And Equipment 0.30 0.42 1.19 0.91 0.33 1.61 1.55 0.61 1.14 0.67 0.19 0.23 0.09 3.54

		2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Investing Activities		-2.77	-2.69	-3.29	-3.07	-2.05	-2.90	-3.20	-95.82	-7.73	-1.39	-0.79	-0.74	-1.05	-3.95
Payments To Acquire Property Plant And Equipment		0.30	0.42	1.19	0.91	0.33	1.61	1.55	0.61	1.14	0.67	0.19	0.23	0.09	3.54

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Net Cash Provided By Used In Financing Activities 1.59 -0.11 2.61 -0.01 5.65 1.53 5.52 5.78 1.33 533.37 0.30 83.89 35.56 1.03

		2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Financing Activities		1.59	-0.11	2.61	-0.01	5.65	1.53	5.52	5.78	1.33	533.37	0.30	83.89	35.56	1.03

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30

Revenues 50.00 60.86 92.38 66.94 75.66 64.51 100.56 56.89 55.20 59.24 88.58 55.48 51.80 48.06

Lemonaid Health Inc NA NA NA NA NA NA 11.50 NA NA NA NA NA NA NA

Variable Interest Entities 8.50 9.00 9.10 10.00 10.40 10.70 11.80 7.60 NA NA NA NA NA NA

Consolidated Entity Excluding Vie NA NA NA NA 10.40 10.70 11.80 7.60 NA NA NA NA NA NA

Consumer And Research Services, Sales Revenue Net, Customer Concentration Risk, Customer B 1.08 10.67 11.19 13.07 14.93 8.25 16.78 8.07 NA NA NA NA NA NA

Consumer And Research Services, Sales Revenue Net, Customer Concentration Risk, Customer C 13.04 9.71 24.36 14.68 17.06 9.63 20.75 9.68 NA NA NA NA NA NA

Consumer And Research Services, Customer B NA NA NA NA 14.93 8.25 16.78 8.07 10.00 11.21 9.70 8.55 9.84 11.83

Consumer And Research Services, Customer C NA NA NA NA 17.06 9.63 20.75 9.68 14.94 8.51 19.82 17.45 6.84 5.85

Consumer And Research Services 50.00 60.86 92.38 66.94 75.66 64.51 100.56 56.89 55.20 59.24 88.58 55.48 51.80 48.01

Therapeutics NA NA NA 66.94 75.66 NA NA 56.89 55.20 NA 0.01 0.00 0.00 0.05

Revenue From Contract With Customer Including Assessed Tax 50.00 60.86 92.38 66.94 75.66 64.51 100.56 56.89 55.20 59.24 88.58 55.48 51.80 48.06

Consumer Services 48.66 47.55 80.92 53.64 56.51 56.06 83.51 46.04 44.49 47.85 78.14 44.09 40.56 34.73

Pgs 39.60 37.03 70.80 42.60 44.84 44.17 71.98 38.37 44.49 47.85 78.14 44.09 NA NA

Research Services 1.34 10.96 11.45 13.30 19.15 8.45 17.05 10.85 10.72 11.39 10.43 11.38 11.25 13.28

Health Care Other 9.06 10.52 10.13 11.04 11.67 11.88 11.53 7.67 NA NA NA NA NA NA

Service 50.00 60.86 92.38 66.94 75.66 64.51 100.56 56.89 55.20 59.24 88.58 55.48 51.80 NA

Consumer Services, Transferred At Point In Time 41.07 40.04 73.40 46.09 49.28 49.05 77.34 41.24 41.40 45.02 NA NA NA NA

Consumer Services, Transferred Over Time 7.58 7.51 7.52 7.55 7.23 7.01 6.17 4.80 3.08 2.83 NA NA NA NA

Pgs, Transferred At Point In Time 34.20 31.76 65.57 37.50 40.11 39.69 68.19 35.09 41.40 45.02 NA NA NA NA

Pgs, Transferred Over Time 5.40 5.27 5.23 5.10 4.73 4.48 3.79 3.28 3.08 2.83 NA NA NA NA

Research Services, Transferred At Point In Time 0.00 2.35 NA NA NA NA NA NA NA NA NA NA NA NA

Research Services, Transferred Over Time 1.34 13.31 11.45 13.30 19.15 8.45 17.05 10.85 10.72 11.39 NA NA NA NA

Health Care Other, Transferred At Point In Time 6.87 8.29 27.49 2.45 9.17 9.36 13.77 1.53 NA NA NA NA NA NA

Health Care Other, Transferred Over Time 2.18 2.24 -17.36 8.59 2.50 2.52 -2.24 6.15 NA NA NA NA NA NA

Service, Transferred At Point In Time 41.07 42.40 73.40 46.09 49.28 49.05 77.34 41.24 41.40 45.02 NA NA NA NA

Service, Transferred Over Time 8.93 18.47 18.97 20.85 26.38 15.46 23.22 15.65 13.80 14.22 NA NA NA NA

2.56 2.17 4.84 2.87 2.84 3.04 5.24 3.06 2.75 3.24 4.89 3.33 2.34 1.61

4.16 14.36 15.82 16.19 19.03 11.97 21.46 10.78 12.34 13.91 13.68 10.72 11.77 13.21

US 42.19 43.33 69.82 46.77 52.55 48.11 71.73 41.74 38.61 40.35 67.62 40.07 36.07 32.36

International NA NA NA NA 23.11 16.41 28.83 15.15 16.59 18.89 20.96 15.40 15.74 15.70

Other Regions 1.09 1.01 1.90 1.11 1.24 1.39 2.13 1.31 1.51 1.74 2.39 1.35 1.63 0.87

GSK 1.10 10.70 11.10 13.10 14.90 8.30 16.80 8.10 10.00 11.20 9.70 8.60 9.80 11.80

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Revenues	50.00	60.86	92.38	66.94	75.66	64.51	100.56	56.89	55.20	59.24	88.58	55.48	51.80	48.06
Lemonaid Health Inc	NA	NA	NA	NA	NA	NA	11.50	NA	NA	NA	NA	NA	NA	NA
Variable Interest Entities	8.50	9.00	9.10	10.00	10.40	10.70	11.80	7.60	NA	NA	NA	NA	NA	NA
Consolidated Entity Excluding Vie	NA	NA	NA	NA	10.40	10.70	11.80	7.60	NA	NA	NA	NA	NA	NA
Consumer And Research Services, Sales Revenue Net, Customer Concentration Risk, Customer B	1.08	10.67	11.19	13.07	14.93	8.25	16.78	8.07	NA	NA	NA	NA	NA	NA
Consumer And Research Services, Sales Revenue Net, Customer Concentration Risk, Customer C	13.04	9.71	24.36	14.68	17.06	9.63	20.75	9.68	NA	NA	NA	NA	NA	NA
Consumer And Research Services, Customer B	NA	NA	NA	NA	14.93	8.25	16.78	8.07	10.00	11.21	9.70	8.55	9.84	11.83
Consumer And Research Services, Customer C	NA	NA	NA	NA	17.06	9.63	20.75	9.68	14.94	8.51	19.82	17.45	6.84	5.85
Consumer And Research Services	50.00	60.86	92.38	66.94	75.66	64.51	100.56	56.89	55.20	59.24	88.58	55.48	51.80	48.01
Therapeutics	NA	NA	NA	66.94	75.66	NA	NA	56.89	55.20	NA	0.01	0.00	0.00	0.05
Revenue From Contract With Customer Including Assessed Tax	50.00	60.86	92.38	66.94	75.66	64.51	100.56	56.89	55.20	59.24	88.58	55.48	51.80	48.06
Consumer Services	48.66	47.55	80.92	53.64	56.51	56.06	83.51	46.04	44.49	47.85	78.14	44.09	40.56	34.73
Pgs	39.60	37.03	70.80	42.60	44.84	44.17	71.98	38.37	44.49	47.85	78.14	44.09	NA	NA
Research Services	1.34	10.96	11.45	13.30	19.15	8.45	17.05	10.85	10.72	11.39	10.43	11.38	11.25	13.28
Health Care Other	9.06	10.52	10.13	11.04	11.67	11.88	11.53	7.67	NA	NA	NA	NA	NA	NA
Service	50.00	60.86	92.38	66.94	75.66	64.51	100.56	56.89	55.20	59.24	88.58	55.48	51.80	NA
Consumer Services, Transferred At Point In Time	41.07	40.04	73.40	46.09	49.28	49.05	77.34	41.24	41.40	45.02	NA	NA	NA	NA
Consumer Services, Transferred Over Time	7.58	7.51	7.52	7.55	7.23	7.01	6.17	4.80	3.08	2.83	NA	NA	NA	NA
Pgs, Transferred At Point In Time	34.20	31.76	65.57	37.50	40.11	39.69	68.19	35.09	41.40	45.02	NA	NA	NA	NA
Pgs, Transferred Over Time	5.40	5.27	5.23	5.10	4.73	4.48	3.79	3.28	3.08	2.83	NA	NA	NA	NA
Research Services, Transferred At Point In Time	0.00	2.35	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Research Services, Transferred Over Time	1.34	13.31	11.45	13.30	19.15	8.45	17.05	10.85	10.72	11.39	NA	NA	NA	NA
Health Care Other, Transferred At Point In Time	6.87	8.29	27.49	2.45	9.17	9.36	13.77	1.53	NA	NA	NA	NA	NA	NA
Health Care Other, Transferred Over Time	2.18	2.24	-17.36	8.59	2.50	2.52	-2.24	6.15	NA	NA	NA	NA	NA	NA
Service, Transferred At Point In Time	41.07	42.40	73.40	46.09	49.28	49.05	77.34	41.24	41.40	45.02	NA	NA	NA	NA
Service, Transferred Over Time	8.93	18.47	18.97	20.85	26.38	15.46	23.22	15.65	13.80	14.22	NA	NA	NA	NA
	2.56	2.17	4.84	2.87	2.84	3.04	5.24	3.06	2.75	3.24	4.89	3.33	2.34	1.61
	4.16	14.36	15.82	16.19	19.03	11.97	21.46	10.78	12.34	13.91	13.68	10.72	11.77	13.21
US	42.19	43.33	69.82	46.77	52.55	48.11	71.73	41.74	38.61	40.35	67.62	40.07	36.07	32.36
International	NA	NA	NA	NA	23.11	16.41	28.83	15.15	16.59	18.89	20.96	15.40	15.74	15.70
Other Regions	1.09	1.01	1.90	1.11	1.24	1.39	2.13	1.31	1.51	1.74	2.39	1.35	1.63	0.87
GSK	1.10	10.70	11.10	13.10	14.90	8.30	16.80	8.10	10.00	11.20	9.70	8.60	9.80	11.80

Plots across concepts

IncomeStatement

Expenses

Balance Sheet

Assets

Current Assets

NonCurrent Assets

PropertyPlantAndEquipmentNet

Liabilities

Current Liabilities

Stockholders Equity

Per Share

CashFlow

NetCashProvidedByUsedInOperatingActivities

NetCashProvidedByUsedInInvestingActivities

OperatingLeaseLiability

LesseeOperatingLeaseLiabilityPaymentsDue

FiniteLivedIntangibleAssets

Line plots across dimensions of each concept

dei:EntityCommonStockSharesOutstanding
us-gaap:StatementClassOfStock
(None,)

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
us-gaap:StatementClassOfStock
(None,)

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
us-gaap:StatementClassOfStock
(None,)

us-gaap:EarningsPerShareBasicAndDiluted
us-gaap:StatementClassOfStock
(None,)

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
us-gaap:StatementClassOfStock
(None,)

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
us-gaap:StatementClassOfStock
(None,)

TTM Greenblatt ROC
_
(None,)

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService
(None,)

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:StatementGeographical
(None,)

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:ProductOrService, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')

us-gaap:Revenues
us-gaap:StatementBusinessSegments
(None,)

us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
('me:ConsumerAndResearchServices', None)

us-gaap:Revenues
us-gaap:ConsolidatedEntities
(None,)

us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType, us-gaap:StatementBusinessSegments
('me:ConsumerAndResearchServices', 'us-gaap:SalesRevenueNet', 'us-gaap:CustomerConcentrationRisk', None)

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation, us-gaap:TransactionType
(None, 'me:SecondarySaleTransaction')

us-gaap:NetIncomeLoss
us-gaap:StatementClassOfStock
(None,)

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
(None,)